KLF11 and osteosarcoma: Genome-wide CRISPR screen led to the identification of a druggable suppressor of sarcoma cancer stem cells, the Krueppel-like factor 11 (KLF11), which if pharmacological activated in synergy with chemotherapy could be improve the success rate for osteosarcoma treatment [73].